3Faivre S, Le Chevalier T, Monnerat C, et al. Phase Ⅰ - Ⅱ and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma[J]. Ann Oncol,2002,13(9) :1479-1489.
4Castellano D,Lianes P,Paz-Ares L,et al. A phase Ⅱ study of a novel gemeitabine plus cisplatin regimen administered every three weeks for non-small-cell lung cancer[ J ], Ann Oncol, 1998,9(4) :457-459.
5Manegold C,ZatlouKal P, Krejey K, et al. Gemcitabine in nonsmall-cell-lung- cancer[J].Invest New Drugs,2000,18( 1 ) :29-42.
6Antor A, Alberola V, Massuti B, et al. Randomized Phase Ⅲ study of Gemcitabine-Cisplatin versus Etoposide-Cisplatin in the Treatment of locally Advanced or Metastatic NSCLC[J]. J C O,1999,17(1) :12-18
7Extra J, Marry M, Brienza S, Pharmacokinetics and safety profile of Oxaliplatin[J]. Semin Oncol, 1998,25(suppl 5) :13-22
8Raymond E,Chaney S,Taamma A,et al. Oxaliplatin:A review of preclinical and clinical studies[ J ].Ann Oncol, 1998,9 ( 7 ) :1053-1071.
9Monnet I, Brienza S, Hugret F et al. Phase Ⅱ Study of oxaliplatin in pour prognosis non-small cell lung cancer, ATTTTT,Association pour le Traitement des Tumeurs Intra Thoraciques[J]. Eur J Cancer,1998,34(7) :1124-1127
